Article    Table of Contents                    Full Text of this article Free    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Koretz, R. L.    Related Articles in PubMed    PubMed Citation    PubMed

PERSPECTIVE

Malignant Polyps: Are They Sheep in Wolves' Clothing?

Ronald L. Koretz, MD

1 January 1993 | Volume 118 Issue 1 | Pages 63-68

One of the arguments supporting the concept that benign adenomatous polyps of the colon degenerate into cancer is the observation of malignancy in polypoid growths known to have been present for years. Although a latent phase—the duration of time between the initial development of a malignancy and the subsequent occurrence of a clinical problem—must exist, this argument implies that this time span is not many years.

If both the prevalence of malignant polyps and the incidence of consequent symptomatic colon cancer were known, the average latent phase could be calculated. In order to estimate this prevalence, I used autopsy data; the estimate was validated using independent data from three colonoscopic screening studies. The annual incidence of all colon cancer in the United States is approximately 150 000 cases.

I estimate that 725 000 people in the United States harbor at least one malignant polyp. Even if all 150 000 cases of colon cancer were associated with symptoms and began as malignant polyps, the average latent phase is 4.8 years. Because some colon cancers are removed while the patient is still asymptomatic (discovered on screening examination) and because at least some colon cancers arise de novo from the mucosa, the average latent phase must be even longer.

These estimates suggest that it cannot be assumed that the histologic finding of cancer in a polyp that has been observed for many years represents "malignant degeneration" of a previously benign neoplasm; such a malignancy may have had that histologic characteristic from the start. Further, histologically ominous lesions (malignant polyps) may often have prolonged benign clinical courses.

Author and Article Information

Olive View Medical Center, Sylmar, California.
Requests for Reprints: Ronald L. Koretz, MD, Department of Medicine, Olive View Medical Center, 14445 Olive View Drive, Sylmar, CA 91342.

Related articles in Annals:

Articles
Effect of Fecal Occult Blood Testing on Mortality From Colorectal Cancer: A Case-Control Study
Joe V. Selby, Gary D. Friedman, Charles P. Quesenberry, Jr., AND Noel S. Weiss

Annals 1993 118: 1-6. [ABSTRACT][Full Text]  

Editorials
Colonic Polyps, Cancer, and Fecal Occult Blood
Jerome B. Simon

Annals 1993 118: 71-72. [Full Text]  

This article has been cited by other articles:

				H. Brenner, M. Hoffmeister, C. Stegmaier, G. Brenner, L. Altenhofen, and U. Haug Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies Gut, November 1, 2007; 56(11): 1585 - 1589. [Abstract] [Full Text] [PDF]

				M. E. Zalis, M. A. Barish, J. R. Choi, A. H. Dachman, H. M. Fenlon, J. T. Ferrucci, S. N. Glick, A. Laghi, M. Macari, E. G. McFarland, et al. CT Colonography Reporting and Data System: A Consensus Proposal Radiology, July 1, 2005; 236(1): 3 - 9. [Full Text] [PDF]

				J. D. Lewis, A. Brown, A. R. Localio, and J. S. Schwartz Initial Evaluation of Rectal Bleeding in Young Persons: A Cost-Effectiveness Analysis Ann Intern Med, January 15, 2002; 136(2): 99 - 110. [Abstract] [Full Text] [PDF]

				G Nusko, B Schneider, I Schneider, C. Wittekind, and E G Hahn Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study Gut, May 1, 2000; 46(5): 651 - 655. [Abstract] [Full Text] [PDF]

				F. Loeve, M. L. Brown, R. Boer, M. van Ballegooijen, G. J. van Oortmarssen, and J. D. F. Habbema Endoscopic Colorectal Cancer Screening: a Cost-Saving Analysis J Natl Cancer Inst, April 5, 2000; 92(7): 557 - 563. [Abstract] [Full Text] [PDF]

				J.-L. Tsao, S. Tavare, R. Salovaara, J. R. Jass, L. A. Aaltonen, and D. Shibata Colorectal Adenoma and Cancer Divergence : Evidence of Multilineage Progression Am. J. Pathol., June 1, 1999; 154(6): 1815 - 1824. [Abstract] [Full Text] [PDF]

				T. R. Levin, A. Palitz, S. Grossman, C. Conell, L. Finkler, L. Ackerson, G. Rumore, and J. V. Selby Predicting Advanced Proximal Colonic Neoplasia With Screening Sigmoidoscopy JAMA, May 5, 1999; 281(17): 1611 - 1617. [Abstract] [Full Text] [PDF]

				J.-L. Tsao, J. Zhang, R. Salovaara, Z.-H. Li, H. J. Jarvinen, J.-P. Mecklin, L. A. Aaltonen, and D. Shibata Tracing Cell Fates in Human Colorectal Tumors from Somatic Microsatellite Mutations : Evidence of Adenomas with Stem Cell Architecture Am. J. Pathol., October 1, 1998; 153(4): 1189 - 1200. [Abstract] [Full Text] [PDF]